NZ CSANZ ASM | Register for Christchurch

Join us in Christchurch NZ

The CSANZ New Zealand Annual Scientific Meeting 2024 is to be held from Thursday 13 June to Saturday 15 June 2024.

Read more about the International keynote speakers here

Planning is under way for a full educational program, with CSANZ working group workshops, nurses symposium and registrar meeting on Thursday, and the Scientific Meeting opening on Friday 14th June. Enjoy the social activities surrounding the meeting providing a great opportunity to network!

Register Now – early bird discounts closing on 15 April 2024.


You are invited to attend the CSANZ NSW Annual Education Day at the Aerial UTS Function Centre on Saturday 4 May 2024 from 9.00am to 4.15pm, following by networking after the presentations.

Benefit and learn from engaging speakers and presentations, with session topics including interventional cardiology, imaging, heart failure and cardiomyopathies, and electrophysiology.

View the Program | Register HERE  OR SCAN the QR CODE above to register

Registration for all attendees is essential and will close by COB Friday 26 April 2024.  The full day Includes morning and afternoon tea, lunch and a fabulous networking opportunity to join the expert presenters at the end of the day. For more information please contact us on [email protected] 



Please find the latest relevant update to the PBS below:

Chronic heart failure
Dapagliflozin (Forxiga®) (10 mg tablet) is now listed on the PBS for the treatment of chronic heart failure where the patient has a left ventricular ejection fraction of greater than 40%. Prescriptions for treatment are Authority Required (STREAMLINED).

Download FAQs from Services Australia

Services Australia has a broad range of educational resources on the Health Professional Education Resources website, including simulations, podcast and an infographic on the Online PBS Authorities system (click on the link below).

HEART, LUNG and CIRCULATION (HLC) – What’s in February edition

Childhood-onset Heart Disease: Announcing a Blueprint for Optimising Care in Australia
The Australian National Standards of Care for Childhood-onset Heart Disease (CoHD) were launched in early February 2024, and the full set of Standards are now published in Heart, Lung and Circulation. Led by Sholler and Selbie, the authorship group of the Standards’ aim is to enable all Australian patients, families and carers affected by CoHD to “live their best and healthiest lives”. Among the 12 standards, transition to adult care, mental health and psychological care, and neurodevelopmental and neurocognitive care, are highlighted for special mention in an invited linked Editorial by Celermajer. Overall, these National Standards of Care present a new paradigm in health care, whereby healthcare professionals, governments and consumers work together to optimise patient care. Further, Celermajer suggests that the Standards could evolve as a “living document” to address further relevant topics, such as prevention of acquired heart disease.


Hypertrophic Cardiomyopathy: Not Such a Rare Disease?
Hypertrophic cardiomyopathy (HCM)—a primary genetic disorder characterised by progressive left ventricular hypertrophy and sudden death—may not be a rare disease, suggest Playford and colleagues. In a comprehensive, 2001-2019 screen of more than 300,000 echocardiographic reports in the National Echo Database Australia (NEDA), they found that about 3% of men and 1.7% of women met criteria for phenotypical HCM; that is, about 17 men and 8 women per 10,000 population, aged ≤ 50 years. Given that HCM is likely to be more common than previously prescribed, seeking a definitive diagnosis early to reduce the risk of developing heart failure early or dying prematurely seems warranted, particularly with expanding treatment options already here or on the horizon.


Cardiac Resynchronisation Therapy: Can Medicare Benefits Criteria Keep up to the Pace?
There is a mismatch between evidence-based international recommendations and current Australian Medicare Benefits Schedule criteria for cardiac resynchronisation therapy (CRT), say Roccisano and colleagues. In a Letter to the Editor, they reported that of 100 consecutive patients who underwent CRT implantation at a single tertiary hospital, just over half fulfilled the Medicare Benefits Schedule criteria for CRT. However, those who did not meet the MBS criteria did have clinical criteria in line with European Society of Cardiology (ESC) recommendations, including in patients with heart failure and reduced ejection fraction (<40%). They say the ESC criteria do fulfil cost-effectiveness and quality-of-life improvement standards, and hope that Medicare can contemporaneously evolve to promote consistent access to CRT throughout the Australian healthcare system.

Compiled by Dr Ann Gregory, Commissioning Editor, Heart, Lung and Circulation

SURVEY | Australian Nurse Educator ECG Survey

You are invited to participate in a survey (Phase I) of the project:

Training and competency of Australian acute care nurses in electrocardiogram interpretation: a nationwide study.

This survey will explore Australian nurse educators’ expectations, training, and assessments of acute care nurses’ competency in electrocardiogram (ECG) interpretation. For this research study, a nurse educator is an umbrella term that denotes nurses with a portfolio or job description of providing education to nurses in a hospital setting.

Your answers may inform the development of an ECG assessment tool, which will be distributed to Australian acute care nurses in Phase II to assess their competency in ECG interpretation.

This is an anonymous voluntary survey will take less than 10 mins. More information about the project and research team is provided at the start of the survey.


This study was approved by the Human Research Ethics Committees of the University of the Sunshine Coast (A231898).

For further information please contact Dr Yingyan Chen Chief Investigator/Project Lead on [email protected]

SURVEY | Accessing TGA Website and reporting adverse events

The TGA has asked for our Member’s feedback on how the TGA can improve the way consumers and health professionals access information on therapeutic goods and report adverse events.

Questions will include your experience, finding and accessing information, with interest on the type of content you would find most useful, and how best (e.g., app, website, social media) you would like to access it.

Also seeking feedback about reporting adverse events, like medicine side effects and problems associated with a medical device, providing critical information to monitor the ongoing performance and safety of therapeutic goods.

Complete the quick survey here

New 2024-2025 STP support projects applications are now open

Apply for Commonwealth funding for Specialist Training Program (STP) support projects through the Royal Australian College of Physicians (RACP). Final review and approval is made by the Department of Health & Aged Care (DoHAC).

The RACP is accepting new applications for upcoming support projects that provide support for, and clearly benefit, existing STP trainees in settings outside traditional metropolitan teaching hospitals, including regional, rural, remote and private facilities.

Projects that provide cultural safety training in Indigenous healthcare settings will also be considered, and these can be whole of college activities aimed at cultural and/or behavioural change.

Please refer to the RACP website for details on eligibility, how to apply and further information.

Applications must be received on or before Monday, 11 March 2024.

RACP SUBMISSION to TGA Consultation: Medicine Shortages in Australia, challenges and opportunities

The Therapeutic Goods Administration (TGA) has opened an important consultation into medication shortages, challenges and opportunities for reform. Read consultation background and direct link to survey here

The RACP intends on making a submission to the consultation subject to sufficient member feedback. Your related knowledge and advice is therefore requested.

The attached discussion paper outlines the consultation focus questions in full. We recommend that you focus your responses on questions 14-25, being most targeted to specialist practice, however broader responses are welcome.

Please respond to the questions by marking up the attached document (above) and forward to [email protected] by no later than Monday 4 March 2024.
NB: Due to the tight timelines in place, delayed feedback may not be incorporated.

Addressing and reducing medication shortages for you and your patients is a priority for the College and your insight is appreciated in advance.

Congratulations to our CSANZ Members recently awarded for their outstanding service to Cardiovascular Research.

Congratulations to Dr Jessica Orchard for receiving the prestigious NSW Ministerial Award for Rising Star in Cardiovascular research 2023 – recognising the outstanding contributions and emerging talents in cardiovascular research. Awarded at the recent Cardiovascular Research Network Awards in Sydney. Hear about Jessica’s journey here on Youtube

Congratulations to FCSANZ, Prof Ben Freedman, Awarded the 2023 NSW Ministerial Award for Cardiovascular Research Excellence. Be inspired! Watch Prof Ben Freedman’s work here on Youtube.

(Photos and videos courtesy of CVRN and the Heart Foundation).

Posts navigation